SHARMEL LITTLE: Open Payments
NPI 1881021798 · KING, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 7 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $0 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
| Madrigal Pharmaceuticals | 1 | $111 |
| Corcept Therapeutics | 1 | $96 |
Products named: ULTOMIRIS, Kerendia, REXULTI, Xolair, REZDIFFRA, Korlym.
Industry payments across NC — which companies pay providers there.
